NEWOMICS
Newomics is an early stage biotechnology company that commercializes innovative and integrative platforms and solutions for personalized healthcare. Its proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.
NEWOMICS
Industry:
Biotechnology Health Care Wellness
Founded:
2018-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.newomics.com
Total Employee:
11+
Status:
Active
Contact:
(510) 833-2811
Total Funding:
15.72 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Edifice Health
Edifice Health is a immunological health and personalized nutrition company offering a novel metric of inflammatory health.
GenoPalate
GenoPalate analyzes genetic data, demographics and lifestyle information to deliver personalized insights for optimal healthy eating.
Humabiologics
Humabiologics is a regenerative medicine startup to address the gap between the gift of donated human tissues and researchers.
Kyra Medical
Kyra Medical is an innovative medical device company focusing on surgical positioning for gynecology, laparoscopy and urology procedures.
Magnolia NeuroSciences
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
InsideTracker
InsideTracker features its platform that analyzes and tracks key biochemical and physiological markers.
Sotera Health
Sotera Health is an integrated global health solutions provider.
Uqora
Uqora is a biotechnology company focused on urinary tract health. Uqora has developed innovative solutions for proactive urinary health.
Current Employees Featured
Founder
Investors List
Photon Fund
Photon Fund investment in Series B - Newomics
LDV Partners
LDV Partners investment in Series B - Newomics
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series B - Newomics
MSA Capital
MSA Capital investment in Series B - Newomics
Photon Fund
Photon Fund investment in Series A - Newomics
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series A - Newomics
Official Site Inspections
http://www.newomics.com Semrush global rank: 5.76 M Semrush visits lastest month: 1.45 K
- Host name: 51.226.196.35.bc.googleusercontent.com
- IP address: 35.196.226.51
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Newomics" on Search Engine
Newomics - Crunchbase Company Profile & Funding
Newomics is an early stage biotechnology company that commercializes innovative and integrative platforms and solutions for personalized healthcare. Its proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for.See details»
Technology | Newomics
Technology. Newomics is developing microfluidic chips for cellular and molecular analysis for precision medicine. Our first product is the M3 …See details»
Newomics, Inc. | LinkedIn
About us. Newomics is a biotech company that sells and develops innovative and integrative platforms for LC-MS. In particular, the award-winning multinozzle M3 emitter, with the MnESI ion source,...See details»
Newomics Announces a Global Network of Distributors
Sep 1, 2020 BERKELEY, Calif.– ( BUSINESS WIRE )–Newomics Inc., a commercial-stage biotechnology company that sells and develops mass spectrometry products and services, today announced it has completed the final link in creating a World-Wide Distribution and Support Network.See details»
Newomics Company Profile - Craft
Overview. Newomics is a biotechnology company that commercializes platforms and solutions for precision medicine. It uses technology based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS). The company aims to analyze molecules from minute amounts of biospecimens such as blood and urine. Type. …See details»
Newomics Closes $7.9 Million Series B Financing to Accelerate …
Dec 1, 2020 Newomics Inc. is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. The company’s products deliver the robustness...See details»
Newomics Launches New Platform for High-Throughput …
Nov 10, 2020 Newomics Inc. is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. The company’s products deliver the robustness...See details»
CORRECTING and REPLACING Newomics Announces …
Mar 3, 2022 Newomics Inc., a biotechnology company commercializing mass spectrometry solutions for molecular detection, today announced collaborations with Bruker Corporation, a company with differentiated...See details»
Newomics Company Profile 2024: Valuation, Funding & Investors …
Newomics Overview. Update this profile. Year Founded. 2011. Status. Private. Employees. 11. Latest Deal Type. 2ndary - Private. Investors. 11. General Information. Description. Developer of a biotechnology platform designed to create multi-omics diagnostic assays for diabetes, Alzheimer's, and other diseases.See details»
NEWOMICS, INC | VentureRadar
Newomics is a biotech company that sells and develops innovative and integrative platforms for LC-MS. In particular, the award-winning multinozzle M3 emitter, with the MnESI ion source, enhances the ionization efficiency to achieve unprecedented sensitivity, throughput, and robustness.See details»
Newomics and Bruker Announce a Collaboration on High …
Mar 9, 2022 Newomics and Bruker Corporation, on March 2nd, 2022, announced a collaboration on a novel LC-MS platform for drug discovery in the Pharma/Biopharma industry as well as research institutions. The two companies agreed on co-marketing Newomics’s Microflow-nanospray Electrospray Ionization (MnESI) product line with …See details»
Newomics Closes $3.9M Series A Round | GenomeWeb
Aug 9, 2018 NEW YORK (GenomeWeb) – Mass spec technology firm Newomics has closed a $3.9 million Series A funding round. The Berkeley, California-based company closed the round on Wednesday, said Daojing Wang, Newomics' founder and CEO, adding that it surpassed its initial target of $3.5 million.See details»
IonOpticks and Newomics broaden chromatography accessibility …
Dec 6, 2023 IonOpticks, the world leader in high performance liquid chromatography for mass spectrometry, is proud to announce an exciting collaboration with Newomics Inc. that has produced an interface...See details»
Newomics - Funding, Financials, Valuation & Investors
Newomics has raised a total of. $15.7M. in funding over 3 rounds. Their latest funding was raised on Dec 1, 2020 from a Series B round. Newomics is funded by 3 investors. Photon Fund and LDV Partners are the most recent investors. Unlock for free.See details»
Newomics Announces a Global Network of Distributors
Sep 1, 2020 BERKELEY, Calif.-- ( BUSINESS WIRE )--Newomics Inc., a commercial-stage biotechnology company that sells and develops mass spectrometry products and services, today announced it has completed the...See details»
Newomics - Contacts, Employees, Board Members, Advisors
Newomics commercializes innovative and integrative platforms and solutions for personalized healthcare.See details»
Newomics and IonOpticks Collaborate to Broaden …
Dec 6, 2023 Newomics and IonOpticks today announced exciting collaborations to interface IonOpticks’ leading chromatography solutions, particularly the Aurora Series columns, with Newomics’ universal ion source for electrospray ionization mass spectrometry or UniESI source, for nano/microflow LC-MS applications.See details»
Newomics - Crunchbase
Companies like Newomics include Truveta, Sotera Health, and Clensta. Pandion Therapeutics Cambridge , Massachusetts , United States 10 Contacts 1-10 employeesSee details»
Newomics - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Newomics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Total Products Active 10. Active Tech Count 40. About. Newomics uses 10 technology products and services including HTML5 , jQuery , and Google Analytics, according to G2 Stack.See details»